Editorial: Personalized Medicine for Urological Cancers: Targeting Cancer Metabolism.
作者信息
Gunter Jennifer H, Kruithof-de Julio Marianna, Zoni Eugenio
机构信息
School of Biomedical Sciences, Faculty of Health, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia.
Australian Prostate Cancer Research Centre-Queensland (APCRC-Q), Translational Research Institute, Queensland University of Technology, Woolloongabba, QLD, Australia.
出版信息
Front Oncol. 2022 Mar 3;12:862811. doi: 10.3389/fonc.2022.862811. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Personalized Medicine for Urological Cancers: Targeting Cancer Metabolism.社论：泌尿生殖系统癌症的个性化医疗：针对癌症代谢
Front Oncol. 2022 Mar 3;12:862811. doi: 10.3389/fonc.2022.862811. eCollection 2022.
2
Current Trends in the Incidence and Survival Rate of Urological Cancers in Korea.韩国泌尿系统癌症发病率和生存率的当前趋势
Cancer Res Treat. 2017 Jul;49(3):607-615. doi: 10.4143/crt.2016.139. Epub 2016 Sep 23.
3
Editorial: Precision Medicine and Translational Research in Urological Oncology.社论：泌尿肿瘤学中的精准医学与转化研究
Front Oncol. 2022 Jul 5;12:967278. doi: 10.3389/fonc.2022.967278. eCollection 2022.
4
Incidence of kidney, bladder, and prostate cancers in Korea: An update.韩国肾癌、膀胱癌和前列腺癌的发病率：最新情况
Korean J Urol. 2015 Jun;56(6):422-8. doi: 10.4111/kju.2015.56.6.422. Epub 2015 May 27.
5
Hospital volume and postoperative survival for three urological cancers: Prostate, kidney, and bladder.三种泌尿系统癌症（前列腺癌、肾癌和膀胱癌）的医院容量与术后生存。
Int J Urol. 2021 Aug;28(8):799-805. doi: 10.1111/iju.14573. Epub 2021 May 28.
6
Current status of organoid culture in urological malignancy.尿路上皮恶性肿瘤类器官培养的研究现状。
Int J Urol. 2022 Feb;29(2):102-113. doi: 10.1111/iju.14727. Epub 2021 Oct 13.
7
The effect of primary urological cancers on survival in men with secondary prostate cancer.原发性泌尿系统癌症对继发性前列腺癌患者生存的影响。
Prostate. 2021 Nov;81(15):1149-1158. doi: 10.1002/pros.24209. Epub 2021 Aug 16.
8
Incidence of prostate and urological cancers in England by ethnic group, 2001-2007: a descriptive study.2001 - 2007年英格兰不同种族前列腺癌和泌尿系统癌症的发病率：一项描述性研究。
BMC Cancer. 2015 Oct 21;15:753. doi: 10.1186/s12885-015-1771-2.
9
Personalized peptide vaccines and their relation to other therapies in urological cancer.个性化肽疫苗及其与泌尿癌症其他疗法的关系。
Nat Rev Urol. 2017 Aug;14(8):501-510. doi: 10.1038/nrurol.2017.77. Epub 2017 May 31.
10
Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers.多中心前瞻性研究验证了一种用于评估泌尿系统癌症患者虚弱程度的定量评估工具的疗效。
Med Oncol. 2019 Sep 13;36(10):88. doi: 10.1007/s12032-019-1313-x.
引用本文的文献
1
Immunosuppressive Signaling Pathways as Targeted Cancer Therapies.作为靶向癌症治疗的免疫抑制信号通路
Biomedicines. 2022 Mar 16;10(3):682. doi: 10.3390/biomedicines10030682.
本文引用的文献
1
A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer.诊断病理学的新技术方法：基于质谱成像的代谢组学在脐尿管癌生物标志物检测中的应用。
Lab Invest. 2021 Sep;101(9):1281-1288. doi: 10.1038/s41374-021-00612-7. Epub 2021 May 21.
2
Evolution of Urothelial Bladder Cancer in the Context of Molecular Classifications.在分子分类学背景下的尿路上皮膀胱癌的演变。
Int J Mol Sci. 2020 Aug 7;21(16):5670. doi: 10.3390/ijms21165670.
3
Lipogenic signalling modulates prostate cancer cell adhesion and migration via modification of Rho GTPases.脂生成信号通过修饰 Rho GTPases 调节前列腺癌细胞黏附和迁移。
Oncogene. 2020 Apr;39(18):3666-3679. doi: 10.1038/s41388-020-1243-2. Epub 2020 Mar 5.
4
Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratification.术前血浆脂肪酸代谢物可提示前列腺癌进展风险，或可用于患者个体化分层。
BMC Cancer. 2019 Dec 16;19(1):1216. doi: 10.1186/s12885-019-6418-2.
5
Involvement of Gastrin-Releasing Peptide Receptor in the Regulation of Adipocyte Differentiation in 3T3-L1 Cells.胃泌素释放肽受体在 3T3-L1 细胞脂肪细胞分化中的作用。
Int J Mol Sci. 2018 Dec 10;19(12):3971. doi: 10.3390/ijms19123971.
6
Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors.安罗替尼（一种口服多靶点酪氨酸激酶抑制剂）在晚期难治性实体瘤患者中的安全性、药代动力学及抗肿瘤特性
J Hematol Oncol. 2016 Oct 4;9(1):105. doi: 10.1186/s13045-016-0332-8.
Zotero 插件